Grant ID RP210102
Awarded On August 18, 2021
Title Deciphering BRCA1-BARD1 E3 Ligase Activity in Genome Maintenance and Tumor Suppression
Program Academic Research
Award Mechanism High Impact/High Risk
Institution/Organization The University of Texas Health Science Center at San Antonio
Principal Investigator/Program Director Weixing Zhao
Cancer Sites Breast, Ovary
Contracted Amount $250,000*

*Pending contract negotiation

Lay Summary

Affected individuals with harmful genetic change (mutations) in BRCA1 have a greatly increased risk (10-40 times higher than people without mutations) of developing breast and ovarian cancers. Furthermore, the majority (approximately 70%) of breast cancers with BRCA1 mutations do not response to advanced cancer treatments (e.g., targeted drugs) and develop resistance to the traditional chemotherapy/radiotherapy quickly, thus display very aggressive tumor behavior with a poor prognosis. As such, there is an urgent need for learning more about cancers with BRCA1 mutations, particularly the triple negative breast cancers, and finding better treatments for these patients. BRCA1 has been well doc...

Read More